Nirmatrelvir
Nirmatrelvir
Nirmatrelvir (pronounced: Nir-ma-trel-vir) is an antiviral medication used in the treatment of COVID-19. It is a part of the protease inhibitor class of drugs, specifically designed to inhibit the main protease of the SARS-CoV-2 virus.
Etymology
The name "Nirmatrelvir" is derived from the combination of the words "virus" and "matrix", indicating its function as a virus matrix inhibitor. The prefix "Nir-" is a common prefix used in the naming of antiviral drugs.
Usage
Nirmatrelvir is used in combination with another antiviral medication, Ritonavir, to treat COVID-19 in adults and pediatric patients. This combination is known as Paxlovid, which is administered orally.
Mechanism of Action
Nirmatrelvir works by inhibiting the main protease of the SARS-CoV-2 virus. This protease is essential for the replication of the virus. By inhibiting this protease, Nirmatrelvir prevents the virus from replicating within the body.
Related Terms
External links
- Medical encyclopedia article on Nirmatrelvir
- Wikipedia's article - Nirmatrelvir
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski